Azerbaijan to conduct world’s first clinical trials of Sputnik V and AstraZeneca combination
Clinical trials will begin till the end of February.
RDIF, The Gamaleya Center, AstraZeneca and R-Pharm had earlier signed a Memorandum of Intent aimed at cooperation in vaccine development, which was announced in December 2020 during a meeting with Russian President Vladimir Putin.
The world’s first combined vaccine use will be conducted in line with clinical trials protocol registered on December 24, 2020.
The study will allow evaluating the immunogenicity and safety of the combined use of Sputnik V and the vaccine jointly developed by AstraZeneca and Oxford University. The research will be carried out over the course of six months in several countries with 100 volunteers recruited in each. ■